Covid-19: Human trials of Oxford vaccine
14 Aug, 2020

Apart from the representatives from the pharma company, some members from regulator Indian Council of Medical Research (.....

Read More
DCGI issues guidelines for pharma giants
23 Sept, 2020

New Delhi: The Drugs Controller General of India (DCGI) has issued a new set of guidelines, focusing on safety, immunoge.....

Read More
Dr Reddy's seeks DCGI nod to conduct pha
03 Oct, 2020

NEW DELHI : The Hyderabad-based Dr Reddy's Laboratories has applied to the Drugs Controller General of India for per.....

Read More
TataMD CHECK to make COVID-19 detection
10 Nov, 2020

World’s first viral diagnostic based on FELUDA CRISPR Cas-9 platform has been developed in India  NEW DELH.....

Read More
Zydus Cadilla completes Phase II trials
13 Nov, 2020

Company’s biological drug, Pegylated Interferon alpha – 2b significantly reduced the viral load in moderatel.....

Read More
Serum Institute denies side effects clai
01 Dec, 2020

After a Chennai-based man claimed that he suffered neurological and psychological side effects taking a shot of Covid-19.....

Read More
Zydus Cadila gets DGCI nod for phase 3 c
05 Dec 2020

In a regulatory filing, Zydus Cadila said it has received approval from the DCGI to start the phase 3 clinical trials in.....

Read More
Covaxin to be available in the first qua
10 Dec, 2020

Covaxin, a vaccine for COVID-19, will be available in the first quarter of next year, said Suchitra Ella, joint managing.....

Read More
CDSCO expert panel seeks more data on co
10 Dec, 2020

NEW DELHI: An expert committee of the Central Drugs Standard Control Organisation (CDSCO) on Wednesday sought additional.....

Read More
AEFI reporting to be done through Co-WIN
17 Dec, 2020

Need to build on the standard principles of AEFI, make it specific to COVID-19 vaccines: Dr V K Paul In the course of.....

Read More
A great milestone in India scientific ca
04 Jan, 2021

Expressing delight over the approval on restricted emergency use of its COVID-19 vaccine Covaxin, Bharat Biotech on Sund.....

Read More
Coronavirus vaccine to cost Rs 219-292 t
05 Jan, 2021

Coronavirus vaccine developed by AstraZeneca and the University of Oxford will cost USD 3-4 per shot ( ?219-292) to the .....

Read More
Vaccine restricted use considered based
06 Jan, 2021

In a pandemic situation, restricted emergency use of vaccines is considered based on safety and immunogenicity data whil.....

Read More
Serum Institute and Bharat Biotech call
06 Jan, 2021

After publicly trading barbs over the efficacy of their respective vaccines, Serum Institute of India chief executive of.....

Read More
PM Modi stated India’s Covid-19
09 Jan 2021

COVID-19 vaccine: India sees international cooperation in this field, particularly with its neighbours, as its duty, Min.....

Read More
Covid-19 Vaccination in India: PMO revea
15 Jan, 2021

Prime Minister Narendra Modi will launch the pan India rollout of the COVID vaccination drive on January 16 and all prep.....

Read More
PM launches India's vaccination drive ag
16 Jan, 2021

New Delhi, Jan 16 (PTI) Prime Minister Narendra Modi on Saturday launched India's COVID-19 vaccination drive and ass.....

Read More
India, China set to lead vaccine distrib
19 Jan, 2021

Moody’s Analytics on Monday said India, along with China, would take lead in the COVID-19 vaccine distribution in .....

Read More
Covid 19 vaccine in India: Zydus Cadila
22 Jan, 2021

Covid 19 vaccine in India: In a major step towards having another Covid-19 vaccine after Serum Institute of India’.....

Read More
Bharat Biotech, SII approach DCGI for us
29 Jan, 2021

ICMR chief Balram Bhargava on Thursday said COVID-19 vaccine manufacturers–Bharat Biotech and Serum Institute&ndas.....

Read More
Dr Reddys eyes to launch Sputnik V vacci
30 Jan, 2021

Dr Reddys Laboratories, which is conducting Phase 3 trials of Russia’s COVID-19 vaccine Sputnik V, believes the ja.....

Read More
Kochi firm PNB Vesper Life completes pha
23 Feb, 2021

The city-based PNB Vesper Life Sciences has successfully completed phase 2 clinical trials of PNB-001 (GPP-Baladol), its.....

Read More
Covid-19 vaccine update: Precisa Medicam
10 March, 2021

Covid-19 vaccine update: Brazilian company Precisa Medicamentos has applied for emergency authorization to use the Bhara.....

Read More
Covid-19 vaccine in India update: Covaxi
12 March, 2021

The Centre on Thursday said Bharat Biotech’s indigenously developed Covaxin is out of the “clinical trial mo.....

Read More
Zydus Cadila seeks DCGI nod for use of h
06 April 2021

Drug firm Zydus Cadila on Monday said it has sought approval from the domestic drug regulator Drugs Controller General o.....

Read More
RDIF expects 50 Mn doses a month of Sput
14 April 2021

The Russian Direct Investment Fund (RDIF) on Tuesday said it expects over 50 million doses of Sputnik V vaccine to be ma.....

Read More
COVID-19: Recommendation of 3rd booster
19 April 2021

NEW DELHI : More data is needed to establish if a third anti-COVID-19 booster dose will be more effective in fighting th.....

Read More
Expert panel to review Meril price exemp
22 April 2021

NEW DELHI : Meril Life Sciences Pvt. Ltd’s request for exemption from price caps for its first locally-made biodeg.....

Read More
Zydus Cadila - Virafin gets emergency us
24 April 2021

Amid a continuous spike in the number of coronavirus cases in India, Zydus Cadila’s Virafin has been granted emerg.....

Read More
Bharat Biotech seeks DCGI nod to extend
26 April 2021

Bharat Biotech has written to the India’s drug regulator seeking extension of the shelf-life of its indigenously d.....

Read More
Molnupiravir approval sought to target e
27 April 2021

After an outcry for remdesivir, there is now yet another experimental anti-viral drug – Molnupiravir to deal with .....

Read More
DRDO developed 2-DG drug could be game-c
15 May, 2021

The 2-DG drug developed by the Defence Research and Development Organisation (DRDO) could be a game-changer in the fight.....

Read More
Will examine data of 2-DG drug for addin
18 May, 2021

The government will consider including India’s first indigenous anti-COVID drug 2-DG in the national COVID-19 trea.....

Read More
BDR Pharma inks licensing pact with Eli
20 May, 2021

Drug firm, BDR Pharma on Wednesday said it has inked a licensing pact with Eli Lilly and Company for the manufacturing a.....

Read More
Dr Reddy - developing new treatment opti
24 May, 2021

Drug major Dr Reddy's Laboratories is working on the development of new treatment options for Covid-19 patients whic.....

Read More
Monoclonal antibody cocktail unlikely to
31 May, 2021

New Delhi: Monoclonal antibody cocktail, used for the treatment of COVID-19, is unlikely to lead to further mutation of .....

Read More
Sun Pharma, Ferring Pharmaceuticals ink
03 June, 2021

Drug major Sun Pharmaceutical Industries on Wednesday said it has entered into a licensing agreement with Ferring Pharma.....

Read More
AIIMS Delhi to start screening children
07 June, 2021

The All India Institute of Medical Sciences (AIIMS), Delhi, will start screening children for clinical trials of indigen.....

Read More
Mankind Pharma launches drug to treat bl
11 June, 2021

Mankind Pharma on Thursday said it has launched Posaconazole Gastro resistant tablets, used to treat black fungus, in th.....

Read More
US denying emergency approval to Covaxin
12 June, 2021

In the view of the US FDA rejecting emergency use authorisation to Bharat Biotech’s Covaxin, the government Friday.....

Read More
India likely to have Covid vaccine for c
24 June, 2021

Noting that children usually have a mild disease but there is a need to develop Covid-19 vaccines for them, AIIMS Delhi .....

Read More
Pfizer in final stages of getting approv
24 June, 2021

New Delhi: US pharmaceutical giant Pfizer on Tuesday said it is in the "final stages" of getting approval for .....

Read More
Serum Institute of India produces over 1
28 June, 2021

Fulfilling its commitment, Serum Institute of India has produced over 10 crore doses of its COVID-19 vaccine Covishield .....

Read More
Drug regulator DCGI refuses to grant eme
02 July 2021

India’s drug regulator has refused to grant emergency-use authorisation to single-dose COVID-19 vaccine Sputnik-Li.....

Read More
Zydus seeks nod for world-first plasmid
02 July 2021

Ahmedabad: Homegrown healthcare and pharmaceutical major Zydus Cadila has applied for emergency use authorisation (EUA) .....

Read More
Mankind Pharma gets DRDO nod to manufact
09 July, 2021

Drug firm Mankind Pharma on Thursday said it has received licence from the Defence Research and Development Organisation.....

Read More
Working actively with Moderna to see how
10 July, 2021

The government said on Friday that it is working actively with COVID-19 vaccine manufacturer Moderna to see how its vacc.....

Read More
DRDO COVID-19 drug: BDR Pharma inks lice
27 July, 2021

BDR Pharma on Monday said it has inked a licensing pact with the Defence Research and Development Organisation (DRDO) to.....

Read More
Hopeful of launching Covovax for adults
06 Aug, 2021

Serum Institute of India CEO Adar Poonawalla on Friday said he is hopeful that Covovax, another COVID-19 vaccine being m.....

Read More
Zydus Cadila likely to get emergency use
10 Aug, 2021

Ahmedabad-based Zydus Cadila's three-dose COVID-19 vaccine ZyCoV-D is expected to get an emergency-use nod from the .....

Read More
Nasal Covaxin phase II & III tri
18 Aug, 2021

NAGPUR: After getting the final nod from the Drug Controller General of India (DCGI) for the second and third phase tria.....

Read More
Zydus Cadila Covid-19 vaccine ZyCoV-D ge
21 Aug, 2021

Indigenously developed Zydus Cadila COVID-19 vaccine ZyCoV-D has received approval for Emergency Use Authorisation from .....

Read More
Granules India gets licence from DRDO to

Developed by DRDO, 2-DG has been granted permission by Drug Controller General of India (DCGI) for emergency use as adju.....

Read More
DCGI nod to phase-I clinical trial of CO

The firm is required to submit the revised clinical trial protocol for immunogenicity to be assessed on Day 42, instead .....

Read More
Hetero’s Tocilizumab biosimilar ge

This authorisation will enable medical practitioners to use the drug for the treatment of COVID-19 in hospitalised adult.....

Read More
Molbio Diagnostics gets DCGI nod for Nip

Nipah virus (NiV) is an emerging zoonotic disease that causes severe disease in humans. Signs and symptoms range from as.....

Read More
No Delta plus variant of COVID-19 found

Additional municipal commissioner (western suburbs) Suresh Kakani said the samples were examined at a genome sequencing .....

Read More
Novavax, SII apply to WHO for emergency

It represents another major milestone in Novavax’s transformation into a commercial global vaccine company and rei.....

Read More
Children less severely impacted by COVID

On inoculation of children against the virus in India, she said there will be vaccines for children. The drug regulator .....

Read More
AstraZeneca Pharma India gets DCGI nod t

The company has received the import and market permission in Form CT-20 from the Drugs Controller General of India for S.....

Read More
ZyCoV-D to be introduced in Covid vaccin

The government on Thursday said Zydus Cadila’s indigenously-developed needle-free COVID-19 vaccine ZyCoV-D will be.....

Read More
Cadila Healthcare gets DCGI nod to condu

Drug firm Cadila Healthcare on Tuesday said it has received permission from the Indian drug regulator for conducting pha.....

Read More
Govt allows export of Russian COVID vacc

The government has permitted the export of Russia’s single-dose COVID-19 vaccine Sputnik Light domestically produc.....

Read More
Biological E seeks DCGI nod for Phase-3

Hyderabad-based pharmaceutical company Biological E has sought permission from India’s drug regulator to conduct t.....

Read More
Covid: Expert panel recommends emergency

An expert panel of India’s Central Drug Authority has recommended granting emergency use authorisation to Bharat B.....

Read More
Govt will decide on COVID vaccination of

The government will take a final decision on vaccinating children and adolescents against coronavirus on the basis of ov.....

Read More
Serum Institute seeks DCGI nod for Covid

The Serum Institute of India on Friday sought permission from the Drugs Controller General of India (DCGI) to manufactur.....

Read More
COVID-19: Zydus Cadila vaccine to be adm

Zydus Cadila’s COVID-19 vaccine ZyCov-D, which has been cleared by India’s drug regulator for those aged 12 .....

Read More
Govt allows SII to export 5 crore doses

The Indian government has permitted export of 5 crore doses of Covovax, a COVID-19 vaccine domestically produced here by.....

Read More
Serum Institute seeks DCGIs approval for

Serum Institute of India has sought from India’s drug regulator approval for Covishield as a booster dose citing a.....

Read More
COVID-19: WHO issues emergency-use listi

The World Health Organisation on Friday issued emergency use listing for anti-Covid vaccine Covovax produced by Serum In.....

Read More
Bharat Biotech seeks nod for Phase-3 tri

Vaccine maker Bharat Biotech has sought regulatory nod to conduct Phase-3 trials of its nasal Covid-19 vaccine that can .....

Read More
Biocon Biologics says clinical study for

Biocon Biologics, an arm of biotechnology major Biocon, on Thursday said the clinical study for its biologic drug Itoliz.....

Read More
DGCI nod to Covaxin for use in children

The Drugs Controller General of India (DCGI) has granted emergency use authorisation to indigenously-developed Bharat Bi.....

Read More
For now, Covaxin likely to be only Covid

Bharat Biotech’s Covaxin is likely to be the only COVID-19 vaccine available, for now, for children in the age gro.....

Read More
Serum Institute seeks full market author

Serum Institute of India (SII) has sought full approval for its Covid-19 vaccine, Covishield. SII has applied to the min.....

Read More
India witnessing exponential rise in no.

India is seeing an exponential rise in the number of coronavirus cases, which is believed to be driven by its Omicron va.....

Read More
Govt expert panel recommends regular mar

An expert panel of India’s central drug authority on Wednesday recommended granting regular market approval to Cov.....

Read More
DCGI grants emergency use permission to

The Drugs Controller General of India has granted emergency use permission to single-dose Sputnik Light Covid vaccine in.....

Read More
DGCI gives nod to SII’s proposal t

The Drugs Controller General of India (DCGI) has approved Serum Institute of India’s proposal to manufacture a vac.....

Read More
Covid-19: DCGI grants restricted emergen

The Drugs Controller General of India has granted restricted emergency use authorisation (EUA) to Biological E’s C.....

Read More
SII seeks permission for phase-3 study o

Serum Institute of India has sought permission from India’s drug regulator to conduct a phase-3 study of its COVID.....

Read More
Govt panel recommends EUA for Covid vacc

An expert panel of the country’s central drug authority has recommended granting emergency use authorisation (EUA).....

Read More
Covid: Govt panel recommends permission

An expert panel of India’s central drug authority has recommended permission for conducting a phase-3 clinical tri.....

Read More
AIIMS Delhi to start booster dose trial

The AIIMS will start the booster dose trial of Bharat Biotech’s intranasal COVID-19 vaccine from Friday. The boost.....

Read More
Covid-19 vaccine: Covovax gets emergency

The Drugs Controller General of India (DCGI) has granted emergency use authorisation (EUA) for the Novavax and Serum Ins.....

Read More
WHO suspends Covaxin supply to UN agenci

The World Health Organization (WHO) has confirmed it has suspended the supply of Covaxin, produced by city-based Bharat .....

Read More
Covid-19 vaccine: Bharat Biotech’s

Bharat Biotech International Ltd (BBIL) on Tuesday said its COVID-19 vaccine, Covaxin, has received emergency use approv.....

Read More
Two-dose ZyCoV-D regimen to help vaccina

Zydus Lifesciences said on Tuesday said a two-dose regimen of ZyCoV-D will help in administering the vaccine against cor.....

Read More
Govt may not allow mixing of Covid vacci

The government may not allow precaution dose of a COVID-19 vaccine other than the one used for primary vaccination in li.....

Read More
Unable to sell Sputnik Light stock, Stel

Unable to sell its huge stock of Covid vaccine Sputnik Light amid the Russia-Ukraine conflict, the Bengaluru-based Steli.....

Read More
Serum Institute of India seeks permissio

The Serum Institute of India (SII) has sought permission from the country’s drug regulator to conduct Phase-3 tria.....

Read More
Corbevax gets nod from DGCI as heterolog

Biological E’s corbevax has become the first vaccine in India to get regulatory approval for a heterologous Covid-.....

Read More
India approves Biological E. COVID shot

India has approved Hyderabad-based drugmaker Biological E's COVID-19 vaccine as the first mix-and-match booster dose.....

Read More
NTAGI to discuss allowing Corbevax as bo

Allowing Biological E’s Corbevax as a booster for those fully vaccinated against COVID-19 with either Covishield o.....

Read More
Covid-19 vaccine for children: Govt pane

An expert panel of India’s central drug authority on Friday recommended granting emergency use authorisation to Se.....

Read More
DCGI approves indigenous mRNA Covid jab

The Drugs Controller General of India (DCGI) on Tuesday approved India’s first indigenously developed mRNA vaccine.....

Read More
SII seeks nod to export 32.4 lakh doses

The Serum Institute has sought the Centre’s approval to export 32.4 lakh doses of the COVID-19 jab Covovax under t.....

Read More
Serum Institute of India to Launch Indig

Serum Institute of India CEO Adar Poonawalla on Tuesday said the company plans to launch its indigenously-developed vacc.....

Read More
Corbevax & Covaxin approved for

With school kids being detected Covid positive in the city, there’s a visible fear amongst parents about the healt.....

Read More
NTAGI panel reviews data for Corbevax as

The National Technical Advisory Group on Immunisation's Covid working group has reviewed the data of Biological E.....

Read More
Covid-19: Govt panel recommends Corbevax

A government panel on Covid immunisation has recommended allowing Biological E’s Corbevax as a precaution dose for.....

Read More
Covid-19: Govt nod for Corbevax as boost

The Union health ministry is expected to soon approve Biological E’s Corbevax as a precaution dose for people abov.....

Read More
Corbevax approved as precaution dose for

The government has approved Biological E’s Corbevax as a precaution dose for those above 18 years fully vaccinated.....

Read More
100 million doses of Corbevax supplied t

Biological E. Ltd (BE) on Thursday said it has delivered 10 crore (100 million) doses of its COVID-19 vaccine, Corbevax .....

Read More
Drug regulator's nod sought for phase-3

Hyderabad-based firm Bharat Biotech has sought permission from the drug regulator to conduct phase-3 study of its intran.....

Read More
DCGI allows Serum Institute to export ma

India's drug regulator has allowed the export of the first produced-in-India vaccine against malaria, developed by s.....

Read More
WHO alert on cough syrups 'alarming', th

The WHO's recent alert linking cough syrups manufactured by an Indian pharmaceutical firm to the deaths of children .....

Read More
DCGI gives nod to SII-manufactured Ebola

 India's first Ebola vaccine manufactured by Serum Institute has been approved by the Drugs Controller General .....

Read More
Vaccine against cervical cancer to be in

India would be in a position to roll out the indigenously developed Human Papillomavirus Vaccine (HPV) against cervical .....

Read More
Biocon starts clinical study to evaluate

Biotechnology major Biocon on Wednesday said it has initiated a clinical study in collaboration with Equillium Inc to ev.....

Read More
WHO drew premature link between children

The WHO drew a premature link between the deaths of children in Gambia and the four India-made cough syrups which advers.....

Read More
Serum Institute seeks drug regulator's a

The Serum Institute of India (SII) has sought the drug regulator's approval for market authorisation of its COVID-19.....

Read More
Hetero's COVID-19 oral drug Nirmacom (ge

 Hetero, a city-based leading pharmaceutical company on Monday announced the receipt of World Health Organisation P.....

Read More
Tergene Biotech gets recommendation from

Aurobindo Pharma Ltd on Tuesday said its joint venture firm, Tergene Biotech, has received a recommendation from the sub.....

Read More
Indian researchers developing treatment

Researchers in India are working on developing an affordable treatment for a rare and incurable genetic disorder called .....

Read More
Govt panel likely to decide on Covovax a

An expert panel of the central drugs regulatory authority is likely to take a decision on Wednesday on granting market a.....

Read More
Govt panel recommends market authorisati

An expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of Ind.....

Read More
Govt to introduce incentive scheme to bo

The Centre is all set to introduce a research linked incentive programme shaped on the lines of the production linked in.....

Read More
Sun Pharma acquires three anti-inflammat

Drug major Sun Pharmaceutical Industries on Monday said it has acquired three anti-inflammatory brands from Mumbai-based.....

Read More
Centre mulls regulations, stringent acti

The Union Health Ministry is mulling regulations and stringent action against e-pharmacies, including banning them compl.....

Read More
Eli Lilly forays into dermatological spa

Drug firm Eli Lilly on Tuesday said it has forayed into the dermatological space in the country with the launch of a pro.....

Read More
Drug developed using DRDO technology get

A critical drug developed on a DRDO technology for radiological and nuclear emergencies has received approval from the D.....

Read More
DCGI says medicines should be sold only

India's drug regulator DCGI has written to drug controllers of all states and Union territories and the Pharmacy Cou.....

Read More